
Sign up to save your podcasts
Or


Send us Fan Mail
Welcome back, Rounds Table Listeners! This week we have a solo episode with Dr. John Fralick, discussing a recently published trial of the GLP-1 receptor agonist semaglutide for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). Here we go!
The Good Stuff:
Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods
By Dr. John Fralick and Dr. Michael Fralick5
1212 ratings
Send us Fan Mail
Welcome back, Rounds Table Listeners! This week we have a solo episode with Dr. John Fralick, discussing a recently published trial of the GLP-1 receptor agonist semaglutide for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). Here we go!
The Good Stuff:
Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods

91,297 Listeners

43,837 Listeners

321 Listeners

549 Listeners

701 Listeners

504 Listeners

3,374 Listeners

1,150 Listeners

68 Listeners

518 Listeners

367 Listeners

260 Listeners

320 Listeners

11,013 Listeners

4,294 Listeners